CEO: John Patrick Kenny

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. It operates through the following segments: Diagnostics and Life Science. The Diagnostics segment consists testing platforms and technologies such as Isothermal DNA Amplification, Rapid Immunoassay, Enzyme-linked Immunoassay, and Anodic Stripping Voltammetry. The Life Science segment distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.


Key numbers

Market Capitalization:1027561271
Shares Outstanding: 42832900
Float: 42078998
Next Earning Date:2020-08-07
TTm EPS: 0.4998
TTm Dividend Rate:
200 days moving average:12.17
50 days moving average: 19.88
One day percent Change: -1.84



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,